<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> of the solid viscera are one of the most common types of pediatric <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Due to the intra-abdominal location of many of these <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, laparotomy and/or bowel resection are often necessary, predisposing patients to postoperative <z:hpo ids='HP_0005214'>intestinal obstruction</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Additionally, chemotherapy and radiation therapy may lead to <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> bowel injury, also potentially predisposing these patients to postoperative <z:e sem="disease" ids="C0021843" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">bowel obstruction</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We reviewed our data over an eleven-year period to identify the incidence of obstruction as well as factors associated with its development </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: A retrospective data analysis of <z:hpo ids='HP_0000001'>all</z:hpo> patients diagnosed with intra-abdominal <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e>, <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo>, <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo>, and Hodgkin's and non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in a single institution from 1997 to 2007 was conducted </plain></SENT>
<SENT sid="5" pm="."><plain>Data collected included demographic factors, operations, incidence of <z:e sem="disease" ids="C0235329" disease_type="Disease or Syndrome" abbrv="">small bowel obstruction</z:e> (SBO) and the use of adjuvant or neoadjuvant <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> therapy </plain></SENT>
<SENT sid="6" pm="."><plain>Patients who developed SBO were compared to those who did not develop obstruction </plain></SENT>
<SENT sid="7" pm="."><plain>Data comparisons were analyzed statistically using Fisher's exact test, 2-tailed Student's t-Test, or chi-square proportional analysis with significance reported for p&lt;0.05 </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: A total of 291 patients were identified during the study period </plain></SENT>
<SENT sid="9" pm="."><plain>Mean age at diagnosis was 8.1+/-5.8 years </plain></SENT>
<SENT sid="10" pm="."><plain>Males accounted for 57% of <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> distribution was as follows: <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e>: 56 (19%); non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>: 71 (24%); Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>: 64 (22%); <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo>: 32 (11%); and <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo>: 68 (24%) </plain></SENT>
<SENT sid="12" pm="."><plain>There were a total of 12 bowel obstructions in 11 patients (3.7%) </plain></SENT>
<SENT sid="13" pm="."><plain>Mean follow-up for <z:hpo ids='HP_0000001'>all</z:hpo> patients was 3.6+/-2.7 years </plain></SENT>
<SENT sid="14" pm="."><plain>Children with <z:e sem="disease" ids="C0021843" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">bowel obstruction</z:e> were more likely to be male (4.5:1, p=0.061) and younger (4.2 years versus 8.1 years; p=0.087) </plain></SENT>
<SENT sid="15" pm="."><plain><z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> accounted for 45% of patients with <z:e sem="disease" ids="C0021843" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">bowel obstruction</z:e>, but made up only 19% of the study population </plain></SENT>
<SENT sid="16" pm="."><plain>The incidence of <z:e sem="disease" ids="C0021843" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">bowel obstruction</z:e> in patients with <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> was 8.9% compared to an overall incidence of 3.8% (p=0.043) </plain></SENT>
<SENT sid="17" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C0021843" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Bowel obstruction</z:e> is relatively uncommon after intra-abdominal <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> in children </plain></SENT>
<SENT sid="18" pm="."><plain><z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e>, <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo> and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> appear to be associated with the highest risk of <z:e sem="disease" ids="C0021843" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">bowel obstruction</z:e> </plain></SENT>
</text></document>